Sale!

Hepatitis C Monitoring Panel Test Cost

Original price was: 2,240 د.إ.Current price is: 2,010 د.إ.

-10%

The Hepatitis C Monitoring Panel Test is a comprehensive diagnostic tool used to assess and monitor the progression or treatment response of Hepatitis C virus (HCV) infection. This panel typically includes a series of blood tests that measure the viral load (quantity of the virus in the blood), check for the presence of antibodies against the HCV, and sometimes assess the virus’s genotype, which can influence treatment decisions. Additionally, liver function tests are often part of the panel to evaluate the impact of the virus on liver health.

At DNA Labs UAE, the cost for the Hepatitis C Monitoring Panel Test is set at 2010 AED. DNA Labs UAE is known for its state-of-the-art facilities and highly qualified staff, ensuring accurate and reliable test results. This test is crucial for individuals diagnosed with or suspected of having Hepatitis C, as it guides healthcare providers in making informed decisions regarding the best course of treatment and monitoring the effectiveness of therapy over time.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HEPATITIS C MONITORING PANEL Test

Test Cost: AED 2010.0

Symptoms, Diagnosis, and Test Components

The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment. The test components include:

  • HCV RNA Quantitative Real Time PCR
  • CBC
  • ALT (SGPT)
  • AST (SGOT)
  • Creatinine, serum
  • Bilirubin, direct
  • Bilirubin, total
  • Urea, serum

Price: AED 2010.0

Sample Condition

3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube and 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes and 3 mL (2 mL min.) serum from 1 SST. Separate plasma within 2 hours of collection. Ship refrigerated. DO NOT FREEZE. 12 hours fasting is recommended. Hemolysed specimens are not acceptable.

Report Delivery

Sample Tue / Fri by 11 am; Report Thu / Mon

Method

DPD, Electrical Impedence, VCS, IFCC, Real Time PCR, Compensated Jaffe’s ReactionIDMS Traceable, Urease UV

Test Type

Disorders of Liver

Doctor

Gastroenterologist

Test Department

Pre Test Information: 12 hours fasting is recommended.

Test Details

The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment. Some of the markers that may be included in the panel are:

  1. Hepatitis C virus (HCV) RNA: This measures the amount of the virus in the blood. A high viral load may indicate active infection.
  2. Liver enzymes: Elevated levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may indicate liver damage caused by the infection.
  3. Liver function tests: These tests measure the levels of various substances in the blood that are produced by the liver. Abnormal levels may indicate liver dysfunction.
  4. Hepatitis C antibody: This test detects the presence of antibodies produced by the immune system in response to Hepatitis C infection. A positive result indicates a current or past infection.
  5. Genotype testing: This determines the specific strain or genotype of the Hepatitis C virus. Different genotypes may respond differently to treatment.
  6. Fibrosis markers: These tests measure the degree of liver fibrosis or scarring. They can help determine the stage of liver disease and guide treatment decisions.

The HEPATITIS C MONITORING PANEL test is typically ordered by healthcare providers to assess the progression of the infection, monitor liver function, and evaluate the effectiveness of antiviral treatment. It is important for individuals with Hepatitis C to undergo regular monitoring to ensure timely intervention and management of the infection.

Test Name HEPATITIS C MONITORING PANEL Test
Components *HCV RNA Quantitative Real Time PCR*CBC *ALT (SGPT)*AST (SGOT)*Creatinine, serum*Bilirubin,direct*Bilirubin, total*Urea, serum
Price 2010.0 AED
Sample Condition 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes AND 3 mL (2 mL min.) serum from 1 SST. Separate plasma within 2 hours of collection.Ship refrigerated. DO NOT FREEZE. 12 hours fasting is recommended. Hemolysed specimensarenotacceptable.
Report Delivery Sample Tue / Fri by 11 am; Report Thu / Mon
Method DPD, Electrical Impedence, VCS, IFCC, Real Time PCR , Compensated Jaffe’s ReactionIDMS Traceable, Urease UV
Test type Disorders of Liver
Doctor Gastroenterologist
Test Department:
Pre Test Information 12 hours fasting is recommended.
Test Details

The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment.

Some of the markers that may be included in the panel are:

1. Hepatitis C virus (HCV) RNA: This measures the amount of the virus in the blood. A high viral load may indicate active infection.

2. Liver enzymes: Elevated levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may indicate liver damage caused by the infection.

3. Liver function tests: These tests measure the levels of various substances in the blood that are produced by the liver. Abnormal levels may indicate liver dysfunction.

4. Hepatitis C antibody: This test detects the presence of antibodies produced by the immune system in response to Hepatitis C infection. A positive result indicates a current or past infection.

5. Genotype testing: This determines the specific strain or genotype of the Hepatitis C virus. Different genotypes may respond differently to treatment.

6. Fibrosis markers: These tests measure the degree of liver fibrosis or scarring. They can help determine the stage of liver disease and guide treatment decisions.

The HEPATITIS C MONITORING PANEL test is typically ordered by healthcare providers to assess the progression of the infection, monitor liver function, and evaluate the effectiveness of antiviral treatment. It is important for individuals with Hepatitis C to undergo regular monitoring to ensure timely intervention and management of the infection.